Our story
Treatment isn’t one size fits all
Our mission is to provide the best opioid addiction treatment without the baggage of rehab. We're driven by science and committed to privacy. Above all, we believe in recommendations, not orders.
What we believe
There’s a proven treatment for opioid addiction, and it’s easier than most people think
Medication-assisted treatment reduces overdoses by 75%, and it’s covered by insurance. It’s just too hard to get. Ophelia is here to change that.
Recovery on your own terms
Rehab requires putting your life on hold, leaving your environment, and living somewhere else for months. Ophelia offers a different kind of solution.
Patients are the experts on themselves
We won’t force you to do anything you don’t want. Quite the opposite. You’re the expert of your own life. We advocate harm reduction because everyone deserves the right to feel safe.
Ophelia’s founder
Zack Gray
Zack started Ophelia after losing someone he loved to an opioid overdose.
He’s a Y Combinator-backed entrepreneur, Columbia University-funded research scholar, and a Wharton MBA graduation speaker. Previously, Zack led customer acquisition for a residential solar startup, which he helped grow to $30M in revenue. He studied astrophysics and philosophy at Columbia University and received his MBA from The Wharton School.
What our patients are saying
Designed by world-leading medical experts
Dr. Arthur Robin Williams
Dr. Arthur Robin Williams is a codesigner of Ophelia and brings a wealth of knowledge on substance use disorders. Currently, he is an academic addiction psychiatrist, and a Research Scientist at New York State Psychiatric Institute supported with NIH, SAMHSA, and CDC funding. He has served as an expert speaker or consultant to the NIH HEAL Initiative, the National Quality Forum, and the American Psychiatric Association to aide quality measure development efforts for the opioid crisis under the OUD Cascade of Care framework.
Dr. Adam Bisaga
Dr. Adam Bisaga codesigned Ophelia alongside Dr. Arthur Williams in order to help patients struggling with opioid addiction. He is an academic addiction psychiatrist and NIH funded researcher developing novel approaches to treat substance use disorders. Dr. Bisaga is a member of the UN Office of Drugs and Crime Expert Panel and has worked with UN agencies internationally training providers and developing treatment guidances.
Ophelia in the news
Using telemedicine to treat opioid addiction
Getting medication long meant seeing a licensed provider. Now a strategy for evading Covid-19 makes treatment available via the web.
Read full story
What you need to know about joining a virtual accelerator now
Michael Seibel from Y Combinator has a message for entrepreneurs: The pandemic hasn't scared off investors.
Read full story
Why venture capital doesn’t build the things we really need
The funding model that made Silicon Valley a global hub excels at creating a certain kind of innovation—but the pandemic has exposed its broader failures.
Read full story
Rehab 2.0: YC-backed Ophelia raises $2.7 million to help people quit opioids without the burden and cost of rehab
Ophelia wants to offer individuals who struggle with opioid addiction medication-assisted treatment (MAT) through its telemedicine platform.
Read full story
Ophelia Health gets menlo ventures backing for opioid-addiction therapy
Startup uses telemedicine to provide medication, counseling for opioid addiction.
Read full story
Using telemedicine to treat opioid addiction
Getting medication long meant seeing a licensed provider. Now a strategy for evading Covid-19 makes treatment available via the web.
Read full story
What you need to know about joining a virtual accelerator now
Michael Seibel from Y Combinator has a message for entrepreneurs: The pandemic hasn't scared off investors.
Read full story
Why venture capital doesn’t build the things we really need
The funding model that made Silicon Valley a global hub excels at creating a certain kind of innovation—but the pandemic has exposed its broader failures.
Read full story
Rehab 2.0: YC-backed Ophelia raises $2.7 million to help people quit opioids without the burden and cost of rehab
Ophelia wants to offer individuals who struggle with opioid addiction medication-assisted treatment (MAT) through its telemedicine platform.
Read full story
Ophelia Health gets menlo ventures backing for opioid-addiction therapy
Startup uses telemedicine to provide medication, counseling for opioid addiction.
Read full story